Behairy, Behairy E <br/><br/>
Safety and Efficacy of 8 Weeks Ledipasvir/Sofosbuvir for Chronic Hepatitis C Genotype 4 in Children Aged 4-10 Years.  [electronic resource] 

 -  The Journal of pediatrics  04 2020 
 - 106-110 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1097-6833 
<br/><br/><label>Standard No.: </label>10.1016/j.jpeds.2019.12.034  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--administration & dosage<br/>Benzimidazoles--administration & dosage<br/>Child<br/>Child, Preschool<br/>Female<br/>Fluorenes--administration & dosage<br/>Genotype<br/>Hepacivirus--drug effects<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Male<br/>Prospective Studies<br/>Sofosbuvir<br/>Time Factors<br/>Treatment Outcome<br/>Uridine Monophosphate--administration & dosage